Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126346641 | 12634664 | 1 | I | 20160610 | 20160727 | 20160809 | 20160809 | EXP | CH-PFIZER INC-2016379658 | PFIZER | 68.00 | YR | M | Y | 100.00000 | KG | 20160809 | OT | CH | CH |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126346641 | 12634664 | 1 | PS | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 20 MG, QD | Y | 20987 | 20 | MG | QD | ||||||
126346641 | 12634664 | 2 | SS | OSTEOSET-T | CALCIUM SULFATETOBRAMYCIN SULFATE | 1 | Intramedullar (bone marrow) | 30 G, UNK | 0 | 30 | G | ||||||||
126346641 | 12634664 | 3 | SS | LISINOPRIL SPIRIG | LISINOPRIL | 1 | Oral | 10 MG, QD | Y | 0 | 10 | MG | QD | ||||||
126346641 | 12634664 | 4 | SS | UVAMIN | NITROFURANTOIN | 1 | Oral | 100 MG, QD | 400 | MG | 0 | 100 | MG | QD | |||||
126346641 | 12634664 | 5 | SS | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Intravenous drip | 2 G, BID | 116 | G | Y | 0 | 2 | G | BID | ||||
126346641 | 12634664 | 6 | C | BELOC /00376903/ | METOPROLOL TARTRATE | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
126346641 | 12634664 | 7 | C | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
126346641 | 12634664 | 8 | C | METFORMIN SPIRIG HC | 2 | Oral | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
126346641 | 12634664 | 9 | C | METHIONIN | METHIONINE | 1 | Oral | 500 MG, TID | 0 | 500 | MG | TID | |||||||
126346641 | 12634664 | 10 | C | REMERON | MIRTAZAPINE | 1 | Oral | 15 MG, QD | 0 | 15 | MG | SOLUBLE TABLET | QD | ||||||
126346641 | 12634664 | 11 | C | LAXOBERON | SODIUM PICOSULFATE | 1 | Oral | UNK | 0 | ||||||||||
126346641 | 12634664 | 12 | C | QUETIAPINE SANDOZ | QUETIAPINE | 1 | Oral | 25 MG, QD | 525 | MG | 0 | 25 | MG | QD | |||||
126346641 | 12634664 | 13 | C | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | 320 | MG | 0 | 20 | MG | QD | |||||
126346641 | 12634664 | 14 | C | DAFALGAN | ACETAMINOPHEN | 1 | Oral | 1000 MG, UNK | 0 | 1000 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126346641 | 12634664 | 2 | Osteomyelitis |
126346641 | 12634664 | 3 | Hypertension |
126346641 | 12634664 | 5 | Osteomyelitis |
126346641 | 12634664 | 8 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126346641 | 12634664 | OT |
126346641 | 12634664 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126346641 | 12634664 | Acute kidney injury | |
126346641 | 12634664 | Drug level increased | |
126346641 | 12634664 | Drug prescribing error | |
126346641 | 12634664 | Toxic encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126346641 | 12634664 | 1 | 20160614 | 0 | ||
126346641 | 12634664 | 2 | 20160520 | 0 | ||
126346641 | 12634664 | 3 | 20160614 | 0 | ||
126346641 | 12634664 | 4 | 20160603 | 20160606 | 0 | |
126346641 | 12634664 | 5 | 20160513 | 20160618 | 0 | |
126346641 | 12634664 | 6 | 20160617 | 0 | ||
126346641 | 12634664 | 7 | 20160617 | 0 | ||
126346641 | 12634664 | 8 | 20160614 | 0 | ||
126346641 | 12634664 | 9 | 20160617 | 0 | ||
126346641 | 12634664 | 10 | 20160617 | 0 | ||
126346641 | 12634664 | 12 | 20160521 | 20160617 | 0 | |
126346641 | 12634664 | 13 | 20160526 | 20160614 | 0 |